Mark Sale received his MD in 1985 from The Ohio State University and an MA in biostatistics from Georgetown University in 1995. Between completing his two graduate degrees, Dr. Sale completed a Fellowship in Clinical Pharmacology at Stanford University and became an Assistant Professor of Medicine and Pharmacology at Georgetown University. In 1998 Dr. Sale joined GlaxoSmithKline and rose to level of Global Director, Research Modeling and Simulation prior to starting an independent consultancy in 2006 in population pharmacokinetics, modeling, and simulation. Dr. Sale has extensive experience conducting complex population PK analyses across diverse therapeutic areas and is one of the pharmaceutical industry’s thought leaders in modeling and simulation.
We sat down with Mark to learn more about his predicted changes in drug development, favorite projects and therapeutic areas he’s worked on, and his advice for new scientists. Listen to the interview: